← All trials
NCT04440696
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 21, 2020
- Primary completion
- Dec 31, 2021
- Completion date
- Apr 29, 2022
- First posted
- Jun 22, 2020
- Last posted
- Oct 29, 2020
- Enrollment
- 48
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of ChinaLead sponsor
- Jilin UniversityOverall official - principal investigator
- Jilin UniversityCollaborator
- Jinlin UniversityOverall official - principal investigator
- Jinlin UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.